Biocompatibles' BiodivYsio Stent To Be Sold By Abbott's Perclose Division

Biocompatibles' BiodivYsio phosphorylcholine-coated stent will be marketed in the U.S. by a direct sales force of about 150 from Abbott Labs' Perclose division, following FDA approval Oct. 3.